Kuala Lumpur, 7 April 2022 – Syarikat Takaful Malaysia Am Berhad (“STMAB” or “Takaful Malaysia”), the general takaful arm of Malaysia’s FIRST takaful operator, Syarikat Takaful Malaysia Keluarga Berhad, honoured and celebrated its best-performing corporate agents at the STMAB Agency Awards 2021. The prestigious awards ceremony, graced by Syarikat Takaful Malaysia Am Berhad Chairman Ismail Mahbob, saw 208 corporate agents receiving awards under four categories for their outstanding sales performance in 2021.      

“Despite the challenging COVID-19 situation, our corporate agents remained steadfast in overcoming challenges to achieve the set targets. We value the commitment demonstrated by our agency force and their dedication in sharing our vision to be a leading general takaful operator and help our customers achieve their aspirations for a brighter and financially secure future. The agency awards ceremony is specially dedicated to celebrating the accomplishments of our valued business partners, and we hope this recognition will continue to drive and motivate them to deliver consistent sales performance year-on-year,” said Mohamed Sabri Ramli, Chief Executive Officer of Syarikat Takaful Malaysia Am Berhad. 

MALAYSIA – April 7, 2022 – Shipsy, a leading SaaS-based logistics management solution provider is going to host its first-ever mega virtual Logistics Tech Summit – LIMITLESS 2022 with the theme ‘Powering The Next Wave of Commerce’ on April 6, 2022. 

The exciting speaker lineup at LIMITLESS 2022 comprises industry stalwarts from marquee organizations like Steve Stanton, Chief Business Officer - Parcels & Express, Emirates Post; Apoorva Kumar, Senior Vice President - Logistics Services, Jumia Group; Sourabh Pandey, CXO - Fulfilment & Experience, Meesho; Bhavik Jhaveri, Senior Director & Head of SCM (Outbound) Products, Myntra; Abhishek Chakraborty, Executive Director, DTDC Express Limited; Vikas Sharma, Senior Vice President - Operations, Zepto; Iyad Kamal, Former Chief Operating Officer, Aramex and Advisor, Shipsy; Soham Chokshi, Co-founder and CEO, Shipsy; and Dhruv Agrawal, Co-founder and COO, Shipsy. 

PETALING JAYA, 7 April 2022 – Malaysian Genomics Resource Centre Berhad (“Malaysian Genomics” or “the Group”), a leading genomics and biopharmaceutical specialist, was recently awarded a COVID-19 surveillance contract by the Institute for Medical Research (“IMR”), the biomedical research arm of the Ministry of Health (“MOH”). Malaysian Genomics is one of the private laboratories that IMR has engaged to outsource genome surveillance of SARS-CoV2. 

Dato’ Alvin Nesakumar, Executive Director of Malaysian Genomics, said, “We are pleased to support IMR and MOH in this important effort to monitor the evolution of the COVID-19 virus, its variants and sub-variants. With our expertise and knowledge in genomics and bioinformatics, we can help IMR track and trace the virus for any variants of concern that the Government needs to be informed of as well as prepare for.”

Malaysian Genomics, whose cell laboratory is the only privately-owned BioSafety Level 2 (“BSL-2”) facility in Malaysia with the Current Good Manufacturing Practice (“cGMP”) certification, is moving towards becoming a premier healthcare provider through the production of CAR T-cells for cancer immunotherapy for solid cancers, as well as other cell engineering services. BSL-2 and cGMP certifications indicate that a laboratory facility has stringent measures for biocontainment standards and ultra-pure laboratory environments to safely work on human cells.

The Group is also ISO 9001:2015, ISO 15189:2014 and ISO 17025:2017 certified under the Integrated Management System.